Yttrium Y-90 Completed Phase 1 Trials for Hepatocellular Carcinoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00846131Y-90 Alone or With Sorafenib for Pre-Transplant Hepatocellular Carcinoma